Research
What is Autoimmune Hypophysitis?
Autoimmune hypophysitis is a chronic inflammation of the pituitary gland that can...
Platelet Counts, Thrombocytopenia, and Lupus
Lupus can have far reaching impacts throughout the body. Low platelet count,...
AI, Machine-Based Learning Software, and Lupus
Will artificial intelligence help us better understand lupus? The answer is yes, through the process of machine learning. (Powered by the correct data of course) “Machine learning” is a term for a type of artificial intelligence or “AI” that adapts and changes how it...
FDA Approves Aurinia Pharmaceuticals’ LUPKYNIS for Adult Patients with Active Lupus Nephritis
LUPKYNIS (voclosporin) is the first FDA-approved oral therapy for lupus nephritis, a condition that causes irreversible kidney damage and increases the risk of kidney failure, cardiac events, and death. On Monday, January 25, 2021, Aurinia Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) approved LUPKYNIS (voclosporin) to...
Hospital Readmission and Severe Lupus Disease Activity
Life with lupus can feel like a revolving door -- between your home, your rheumatologist's office, and the hospital. There are many costs associated with hospital readmission, including lost time and risk of catching a disease. So, how can Lupus Warriors and hospitals work together to avoid...
New Lab Test Identifies Lupus Flare Risk 12 Weeks in Advance
New blood test, aiSLE™ DX Flare Risk Index, identifies lupus flare risk up to 12 weeks in advance. The lab test is now available for clinical use. Note: Progentec Diagnostics, Inc., the company that developed aiSLE™ DX Flare Risk Index, also powers LupusCornerLife with lupus comes...
Coronavirus and Lupus | Things to Know
Coronavirus, also known as COVID-19, is a respiratory disease related to the common cold. Although most healthy people do not need to worry about the disease, people with lupus should be careful. This disease has been in the news lately, and COVID-19 (short for Coronavirus disease 2019) may well be...
Cenerimod: A Potential New Lupus Medication
Research is underway to measure the effectiveness of Cenerimod, a new lupus medication. Early evidence suggests it can help reduce symptoms and prevent flares. Cenerimod is a new medication being developed by the company Idorsia. It is an agonist and modulator for the
NIH Funding and Lupus
The National Institute of Health, or NIH, is a part of the federal government that is responsible for funding, facilitating, and conducting research that improves the health of the nation and the world. Autoimmune diseases, including lupus, are a major health problem for the American people. Because of...
What is the World Health Organization?
The World Health Organization is an international organization dedicated to improving the health of people all over the world through education, aid work, & research. Who is the WHO? (For once, I'm not talking about the rock opera writing, legendary band!) The World...
TULIP 2 Phase III and Type 1 Interferon Lupus Treatments
Anifrolumab, a promising type 1 interferon medication, passed its second Phase III trial. The new treatment is now eligible for approval for the treatment of lupus. Type 1 interferon medications are promising candidates for treating lupus because they reduce inflammation and temper...